Navigation Links
Astrix Technology Group Awarded Department of Homeland Security BioWatch Laboratory Staffing Contract
Date:8/10/2012

RED BANK, N.J., Aug. 10, 2012 /PRNewswire/ -- Astrix Technology Group (Astrix) announced today it has been awarded the Laboratory Staffing Contract to support the Department of Homeland Security (DHS) Office of Health Affairs (OHA) BioWatch Program. The award is a five-year contract consisting of a base period and four option years with the total amount of the award exceeding $75 million.

The mission of the BioWatch Program is to provide and maintain a continuous bio-terrorism air monitoring system in large metropolitan areas. The Program coordinates with state and local public health communities to prepare for and respond to a bioterrorist event. Established in 2003, BioWatch continuously monitors select urban environments twenty-four hours a day, seven days a week.

Acting as the small business Team Lead in response to the Department of Homeland Security solicitation, Astrix partnered with A-TEK, the firm that has been supporting the contract for the previous eight years. The teaming arrangement between Astrix and A-TEK will allow the two companies to share and implement best practices to staff and support the BioWatch laboratories to help fulfill the Program's objectives.

"We are committed to working with our partner A-TEK to provide the highest level of quality and service to the Department of Homeland Security BioWatch program," stated Richard Albert, Chief Executive Officer of Astrix.

Astrix, founded in 1995, provides consulting and staffing services to the scientific community. In addition to the federal government, Astrix's clients include state, local government and industry leading private sector firms in the chemical, biotech, medical device, pharmaceutical and food/beverage sectors. For more information on Astrix, please visit http://www.astrixinc.com.

CONTACT:
Michael Zachowski, Government Programs Director
Astrix Technology Group
Phone 732.661.0400 x19
mzachowski@astrixinc.com

This press release was issued through eReleases® Press Release Distribution. For more information, visit http://www.ereleases.com.


'/>"/>
SOURCE Astrix Technology Group
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Global Marine Biotechnology Industry
2. Frost & Sullivan Recognizes MicroProtein Technologies for its Path-Breaking Production Technology for Recombinant Proteins in Bacteria
3. First Plant Genomics Yield Technology Progresses
4. RIT professor receives National Science Foundation grant to improve on-chip networks with wireless technology
5. Verenium Corporation And Alexandria Real Estate Equities, Inc. Celebrate The Grand Opening Of A New State-of-the-art Biotechnology Facility
6. Afraxis and PsychoGenics Form Alliance to Offer Afraxis ESP Technology for Drug Discovery
7. Shape-shifting materials are goal of new nanotechnology project
8. Oramed Pharmaceuticals Granted 2nd Patent in New Zealand; 3rd Patent for Core Technology on Oral Delivery of Proteins
9. Life Technologies to Accelerate Development of Ion Torrent Semiconductor Technology for Proteomic Applications in Research, Applied and Clinical Markets
10. New silk technology preserves heat-sensitive drugs for months without refrigeration
11. University of Nottingham to play key role in European solar energy technology project
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... 2017 Agenus Inc. (NASDAQ: AGEN), an immuno-oncology ... cancer vaccines, today announced participation at the following conferences: ... Blair and Maidstone Life Sciences conference "Cancer Immunotherapy Conference" ... New York, NY . Agenus will participate ... 9:40 am: Robert B. Stein , M.D., Ph.D., ...
(Date:3/23/2017)... 23, 2017  SeraCare Life Sciences, Inc., a ... vitro diagnostics manufacturers and clinical laboratories, is ... multiplexed Inherited Cancer reference material ... next-generation sequencing (NGS). The Seraseq™ Inherited Cancer DNA ... from industry experts to validate the ability ...
(Date:3/23/2017)... NEW YORK , March 23, 2017 ... ... causes of death, putting significant strain on health care systems, ... of cancer diagnoses rises, so too does the development of ... with minimum side effects. Among the many types of cancer ...
(Date:3/22/2017)... N.Y. , March 22, 2017 Regeneron Pharmaceuticals, ... the Regeneron Genetics Center (RGC), U.K. Biobank and GSK to ... the U.K. Biobank resource. The initiative will enable researchers to ... new medicines for a wide range of serious and life ... ...
Breaking Biology Technology:
(Date:2/27/2017)... --  Strategic Cyber Ventures , the industry,s first cybersecurity ... million investment in  Polarity , the first commercial human ... based and is led by cybersecurity veterans Tom ... Gula , also a longtime cybersecurity veteran and founder ... A round of funding. This new funding will be ...
(Date:2/21/2017)... February 21, 2017 Der weltweite ... wachsen. Nach einem Gespräch mit mehr als 50 Vertretern aus ... zu überwinden gilt, um diese Prognose zu realisieren. ... ... Mobilisierung der finanziellen Mittel für die Biobank, die Implementierung ...
(Date:2/10/2017)... 2017 Research and Markets has ... Medicine - Scientific and Commercial Aspects" to their offering. ... ... integrated with therapy for selection of treatment as well for ... prevention of disease in modern medicine. Biochip/microarray technologies and next ...
Breaking Biology News(10 mins):